ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

NCI Charging Use Fee for Compounds In Repository

August 12, 1983

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981